Direct Prediction of VLCADD Severity Using Newborn Screening Analyte Data
{{output}}
A critical concern of newborn screening (NBS) for very-long chain acyl-CoA dehydrogenase deficiency (VLCADD) is the difficulty of predicting clinical outcomes. To address this, we investigated neonatal C18:2-carnitine concentrations as a possible predictor of ... ...
